Releasing the brake on the immune system: The PD-1 strategy for hematologic malignancies

Locke J. Bryan, Leo I. Gordon

Research output: Contribution to journalArticle

11 Scopus citations


Incorporation of PD-1 blockade into the treatment algorithms for hematologic malignancies is currently being pursued in multiple active clinical trials. Here we review the data on anti–PD-1 monoclonal antibodies to date and discuss ongoing and future clinical trials.

Original languageEnglish (US)
JournalONCOLOGY (United States)
Issue number6
Publication statusPublished - Jun 15 2015
Externally publishedYes


ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this